Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > AGM, BoD and CEO
View:
Post by Sailboatdream on May 21, 2021 10:25am

AGM, BoD and CEO

Many intelligent and relevant comments in the last 2 days.  I would not equate looking at facts, past performance and critical thinking with cynicism.

what many of us are worried about is having the stock price plateau in the same range for the next 12 years as it did between 2009 and 2021.  There were good reasons back then, but these are no longer valid since Dr. W presentation in Jan 2021.  Back to what worries long term investors, did we just miss a window of opportunity to make a fantastic deal?  We don't want our investments to be dead money for another 10 years.  Unfortunately, this is what history shows.

BoD... presumably, Dr. W results were known by management and BoD prior to being announced.  Why were discussions and deal strategy prepared ahead of time?  It felt a bit reactive last winter.  They should be questioned on this at the next AGM.

CEO... it is normal and even healthy to question if we have the right CEO for a given phase of a company's development.  Product development vs. growth vs. consolidation vs. strategic deal.  What we need right now is a deal maker and a closer.  This is not a repudiation of Dr. T's past work.  Merely a recognition of where we are now.  If this is done well and the BoD launches a search for the right profile of replacement CEO, the share price will likely benefit.  Dr. T would remain a an executive capacity on the research and clinical side.  In any case, the company's present and future cannot rest solely on Dr. T's shoulders.  At the very least, the BoD should be questioned on succession planning at the AGM.

AGM voting... when I receive the package, I am withholding all my votes.  There is no harm done as all of these folks can be voted in at the AGM.  Best case, withholding my votes makes a difference.  Worse case, it sends a strong message.

Additional info... an acquaintance recently spoke with folks at Sernova.  

-  progress on patient 1 and other participants.  No announcements due to alignment of clinical protocols with JDRF milestones for easier payments 
-  recruitment of key personnel... not through Sernova career website or job boards but rather via specialized recruitment firms
-  valuation... apparently continues to be top of mind for management

cheers

Comment by BioTeck on May 21, 2021 11:58am
Valuation has been the top priority for a while now and they can't even keep it stable let alone inflate it. Phil, the fluffing methodology doesn't apply to inflating share price as it would with other things, it actually works the opposite. Depending on how the AGM goes and what news is released before it will determine my future in this stock. I think there is way too much resitance now ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities